Paula K. J. Lee

Paula K. J. Lee

Auto-generated profile, based on publicly available information

Paula K. J. Lee

Department of Neurology, University of Iowa, 200 Hawkins Drive, 8820 JPP, Iowa City, IA, 52242, United States; Iowa City VA Health Care System, Iowa City, IA, United States

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Cell Stem Cell
Verified
Journal Article
Closed access
MCMiles Cunningham
Miles Cunningham
JCJun-Hyeong Cho
Jun-Hyeong Cho
ALAmanda Leung
Amanda Leung
GSGeorge Savvidis
George Savvidis
SASandra Ahn
Sandra Ahn
SCSangmi Chung
Sangmi Chung

1 June 2014 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MMMinho Moon
Minho Moon
HKHyo Geun Kim
Hyo Geun Kim
JCJin Gyu Choi
Jin Gyu Choi
HOHyein Oh
Hyein Oh
PLPaula Kj Lee
Paula Kj Lee
Myung Sook OhMyung Sook Oh
Myung Sook Oh

25 August 2014 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
MMMinho Moon
Minho Moon
IJInhye Jeong
Inhye Jeong
CKChun‐Hyung Kim
Chun‐Hyung Kim
JKJihong Kim
Jihong Kim
PLPaula K. J. Lee
Paula K. J. Lee
KKKwang‐Soo Kim
Kwang‐Soo Kim
The functional roles of the orphan nuclear receptor, Nurr1, have been extensively studied and well established in the development and survival of midbrain dopamine neurons. As Nurr1 and otherNR4A members are widely expressed in the brain in overlapping and distinct manners, it has been an open question whether Nurr1 has important function(s) in other brain areas. Recent studies suggest that up‐regulation of Nurr1 expression is critical for cognitive functions and/or long‐term memory in forebrain areas including hippocampal formation. Questions remain about the association between Nurr1 expression and Alzheimer's disease (AD) brain pathology. Here, using our newly developed Nurr1‐selective antibody, we report that Nurr1 protein is prominently expressed in brain areas with Aβ accumulation, that is, the subiculum and the frontal cortex, in the 5XFAD mouse and that Nurr1 is highly co‐expressed with Aβ at early stages. Furthermore, the number of Nurr1‐expressing cells significantly declines in the 5XFADmouse in an age‐dependent manner, accompanied by increased plaque deposition. Thus, our findings suggest that altered expression of Nurr1 is associated withADprogression. image Using our newly developed Nurr1‐selective antibody, we show that Nurr1 protein is prominently expressed in brain areas accumulating amyloid‐beta (Aβ) in the transgenic mouse model of Alzheimer's disease (AD) and that Nurr1 is highly co‐expressed with Aβ at early stages (upper panel). Furthermore, in the AD brain the number of Nurr1‐expressing cells significantly declines in an age‐dependent manner concomitant with increased Aβ accumulation (lower diagram) highlighting a possible Nurr1 involvement in AD pathology.

1 January 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MMMinho Moon
Minho Moon
HKHyo Geun Kim
Hyo Geun Kim
JCJin Gyu Choi
Jin Gyu Choi
HOHyein Oh
Hyein Oh
PLPaula Kj. Lee
Paula Kj. Lee
Myung Sook OhMyung Sook Oh
Myung Sook Oh

26 November 2019 in Neurology
Verified
Journal Article
Open access
PDF file
PLPaula K.J. Lee
Paula K.J. Lee
JSJuan E. Small
Juan E. Small
MVMichal Vytopil
Michal Vytopil

14 April 2026 in Neurology
Verified
Journal Article
Closed access
JCJack Caplan
Jack Caplan
LVLaura Vilella
Laura Vilella
PLPaula Lee
Paula Lee
RNRoshni Nair
Roshni Nair
DDDeidre Dragon
Deidre Dragon
RSRup K. Sainju
Rup K. Sainju
Severe hypoxemia after generalized convulsive seizures (GCSs) can trigger neural injury and is a potential biomarker for sudden unexpected death in epilepsy (SUDEP). Some degree of variability in interbreath interval is normal, but increased variability may suggest dysfunctional breathing control and may be associated with severe postictal hypoxemia. We evaluated the relationship between interictal breathing variability and severity and duration of hypoxemia after GCS. We prospectively collected video-EEG, respiratory flow and effort, pulse oximetry (SpO2), and ECG from people with epilepsy (PWE). Measures of interictal interbreath interval variability (coefficient of variation, root mean square of successive differences [RMSSD], and long-term [SD-2] variability from Poincaré plots) from interictal asleep and awake periods and other relevant variables were evaluated as covariates for primary outcomes: (1) hypoxemia duration (length of time SpO2 <90%) and (2) severity of hypoxemia (SpO2 nadir), and secondary outcome: occurrence of combined prolonged and pronounced hypoxemia. Univariable and multivariable models were created for primary outcomes, but only univariable analyses were performed for the secondary outcome. Of 2,506 participants enrolled, 257 (141 [∼54%] female; mean age = 37.9 years) had ≥1 GCS, but only 152 GCS in 123 had evaluable respiratory data. Multivariable model for hypoxemia duration showed that SpO2 nadir (mean ratio [MR] = 0.88, 95% CI 0.81-0.96, p = 0.002) and SD-2 of the awake interbreath interval (MR = 1.06, 95% CI 1.01-1.13, p = 0.04) were significantly associated. RMSSD of the non-REM interbreath interval (mean difference = -5.01, 95% CI -8.10 to -1.93, p = 0.002) was the only variable significantly associated with hypoxemia severity after controlling for duration of postictal generalized EEG suppression, SD-2 of the awake interbreath interval, and body mass index. Univariable analyses for combined prolonged and pronounced hypoxemia showed SD-2 of the awake interbreath interval, temporal lobe epilepsy, ictal central apnea, and a shorter tonic phase duration were significantly associated. Measures of interictal respiratory variability are associated with severe and prolonged hypoxemia after GCS. Increased interictal respiratory variability suggests baseline respiratory dysregulation in some PWE and may be a surrogate for SUDEP risk.